2. Academic Validation
  3. Soft-tissue Sarcomas

Soft-tissue Sarcomas

  • Indian J Orthop. 2018 Jan-Feb;52(1):35-44. doi: 10.4103/ortho.IJOrtho_220_17.
Domagoj Ante Vodanovich 1 2,  Peter F M Choong 1 2 3
Affiliations

Affiliations

  • 1 Department of Orthopaedics, St. Vincent's Hospital Melbourne, Victoria, Australia.
  • 2 Department of Surgery, St. Vincent's Hospital Melbourne, University of Melbourne, Victoria, Australia.
  • 3 Bone and Soft Tissue Sarcoma Service, Peter MacCallum Cancer Centre, Victoria, Australia.
PMID: 29416168 DOI: 10.4103/ortho.IJOrtho_220_17
Abstract

This article discusses the epidemiology, diagnosis, and management of primary soft-tissue sarcomas (STS). These musculoskeletal tumors are a rare and heterogeneous group of malignancies, which are best managed by multidisciplinary teams in specialist sarcoma referral centers. Historically, the standard for local control of these tumors has been amputation. Evolutions in multimodality treatment have seen a shift toward preservation of the limb. Advances in limb-sparing surgery have seen the quality of life in sarcoma patients to improve drastically; however, unplanned surgical excision of STS remains a major treatment dilemma in the control of local disease.

Keywords

Limb-sparing surgery; Sarcoma; biopsy; limb prosthesis; musculoskeletal oncology; orthopedic tumors; sarcoma; soft-tissue sarcoma; tumors; unplanned excision of sarcoma.

Figures